Camber Capital Management

Camber Capital Management as of Sept. 30, 2016

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 34 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 21.5 $487M 2.3M 216.30
Teva Pharmaceutical Industries (TEVA) 12.2 $276M 6.0M 46.01
Gilead Sciences (GILD) 7.7 $174M 2.2M 79.12
Mylan Nv 6.5 $148M 3.9M 38.12
Perrigo Company (PRGO) 5.0 $112M 1.2M 92.33
Endo International (ENDPQ) 3.8 $85M 4.2M 20.15
Select Medical Holdings Corporation (SEM) 3.6 $81M 6.0M 13.50
Medicines Company 3.3 $76M 2.0M 37.74
Genomic Health 3.1 $71M 2.5M 28.92
Cardiovascular Systems 3.1 $71M 3.0M 23.74
Brookdale Senior Living (BKD) 3.1 $70M 4.0M 17.45
Orthofix International Nv Com Stk 2.8 $64M 1.5M 42.77
Livanova Plc Ord (LIVN) 2.6 $60M 1.0M 60.11
Community Health Systems (CYH) 2.5 $58M 5.0M 11.54
Tenet Healthcare Corporation 2.5 $57M 2.5M 22.66
Nektar Therapeutics (NKTR) 2.4 $55M 3.2M 17.18
Universal American 2.0 $45M 5.9M 7.65
Alkermes (ALKS) 1.9 $44M 937k 47.03
Valeant Pharmaceuticals Int 1.4 $31M 1.3M 24.55
CONMED Corporation (CNMD) 1.3 $30M 750k 40.06
BioScrip 1.3 $29M 10M 2.89
Ptc Therapeutics I (PTCT) 1.2 $28M 2.0M 14.01
Invitae (NVTAQ) 0.9 $21M 2.4M 8.76
Arena Pharmaceuticals 0.8 $18M 11M 1.75
Syneron Medical Ltd ord 0.7 $17M 2.3M 7.16
AMAG Pharmaceuticals 0.7 $15M 611k 24.51
Endologix 0.6 $13M 1.0M 12.80
Protalix BioTherapeutics 0.3 $7.4M 13M 0.56
Catabasis Pharmaceuticals 0.3 $6.2M 1.0M 6.16
Innocoll 0.3 $6.2M 1.1M 5.88
Protalix Biotherapeutics Inc note 4.500% 9/1 0.2 $5.7M 9.0M 0.63
Targacept Inc Conv Dtd convertible 0.1 $1.7M 1.7M 1.00
Dextera Surgical 0.1 $1.6M 838k 1.89
Biolase Inc warrants 0.0 $0 7.2M 0.00